Skip to content

A Study to See if a Millet-Based Food Helps Control Blood Sugar and Improve Nutrition in People with Type 2 Diabetes

A Randomized Controlled Clinical Trial Evaluating the Efficacy of a Millet-Based Formulation on Glycemic Regulation and Nutritional Status in Patients with Type 2 Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094780
Enrollment
94
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

Intervention1: Millet-Based Formulation: The intervention consists of a ready-to-eat Little Millet Upma Mix, developed as a nutritional/food product in the form of a packed, rehydratable functional fo

Sponsors

DST-SHRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 30 70 years Diagnosed with Type 2 Diabetes Mellitus (as per ADA 2023 guidelines) HbA1c between 6.5% and 9.0% On stable oral hypoglycemic agents for at least 3 months Willing to replace dinner with study formulation Provided written informed consent

Exclusion criteria

Exclusion criteria: Insulin-dependent diabetics Chronic liver, kidney, thyroid dysfunction or cardiac diseases History of gastrointestinal disorders Allergy to millets or cereal grains Pregnant or lactating women Participation in other clinical trials in the last 3 months

Design outcomes

Primary

MeasureTime frame
Change in HbA1c, FBS, PPBS, and OGTT response Change in vitamins (A, B2, B6, B12, D3) and microminerals (Magnesium, Calcium, Zinc, Phosphorus, Manganese, Copper, Selenium)Timepoint: Baseline (0th day) and Day 90

Secondary

MeasureTime frame
Change in Liver Function Tests (LFT), Renal Function Tests (RFT), and Lipid profile (TC, LDL, HDL, TG) Change in hematological profile (CBC) and Quality of Life (QOL) using a validated diabetes-specific QOL scaleTimepoint: Baseline (oth day) and Day 90

Countries

India

Contacts

Public ContactDr Vijaya R

Pankajakasthuri Ayurveda Medical College and PG Centre

vijivijayan5225@gmail.com6238651628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026